Nasso Chiara, Mecchio Anna, Rottura Michelangelo, Valenzise Mariella, Menniti-Ippolito Francesca, Cutroneo Paola Maria, Squadrito Violetta, Squadrito Francesco, Pallio Giovanni, Irrera Natasha, Arcoraci Vincenzo, Altavilla Domenica
Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
Front Pharmacol. 2020 Jul 17;11:1090. doi: 10.3389/fphar.2020.01090. eCollection 2020.
Children represent one of the most susceptible groups to adverse drug reactions (ADRs), as a consequence of physiological growth and maturation of different organ systems. The aim of this study was to characterize the frequency, preventability and seriousness of ADRs recorded in the Pediatric Emergency Department (ED) of the University hospital of Messina, in Sicily. All the suspected adverse reactions to drugs and vaccines collected from 2012 to 2018 were selected and then analyzed. Only adverse drug reactions (ADRs) with a probable or possible causality assessment were included, according to the Naranjo Algorithm and the World Health Organization criteria; the preventability assessment using Schumock and Thornton criteria was also carried out. The Medical Dictionary for Regulatory Activities (MedDRA) was used to group ADRs. Of 75,935 admissions to the Pediatric ED, 120 were due to suspected ADRs. The rate of hospital admission due to ADRs (75.8%) was significantly greater than that of patients without ADRs (11.9%). Among pediatric patients with ADRs the median (Q1-Q3) age was 29.5 (12-73.25) months. Most of ADRs were observed in infants and children (43.3% and 41.7%, respectively vs adolescents, 15%). In addition, in children with ADRs, females [41 (14-105)] were older than males [23 (11-45)] (p=0.044). Most adverse reactions were serious (75.8%) and 20.8% were preventable or probably preventable; however, the majority of serious ADRs (93.4%) resulted without sequelae. The reactions were found to be as probable (54.2%) or possible (45.8%). Vaccines (n=63), antibacterials (n=31) and anti-inflammatory medicines (n=14) were the most frequently drugs involved. Organ toxicity mapping due to vaccines was general disorders and administration site conditions (65.1%), nervous disorders (50.2%), cutaneous disorders (35%), followed by gastrointestinal disorders (20.6%). Cutaneous disorders (76%) gastrointestinal (20.7%), general (15.5%), and nervous disorders (8.6%) were the organ toxicity mapping due to drugs. Active pharmacovigilance has an essential role in supporting the development of strategies aimed at intervention to reduce admissions due to ADRs. Our data suggest that ADRs represent the first cause of hospitalization to the Pediatric Emergency Department. Furthermore, according to the literature, vaccines and antibiotics are the most frequent cause of adverse drug reactions in children.
由于不同器官系统的生理生长和成熟,儿童是药物不良反应(ADR)最易感的群体之一。本研究的目的是描述在西西里墨西拿大学医院儿科急诊科记录的ADR的发生频率、可预防性和严重程度。选取并分析了2012年至2018年收集的所有疑似药物和疫苗不良反应。根据Naranjo算法和世界卫生组织标准,仅纳入因果关系评估为“很可能”或“可能”的药物不良反应;还使用Schumock和Thornton标准进行了可预防性评估。使用《医学监管活动词典》(MedDRA)对ADR进行分类。在儿科急诊科的75935例住院病例中,120例是由疑似ADR引起的。因ADR住院的比例(75.8%)显著高于无ADR患者(11.9%)。在患有ADR的儿科患者中,年龄中位数(Q1-Q3)为29.5(12-73.25)个月。大多数ADR发生在婴儿和儿童中(分别为43.3%和41.7%,而青少年为15%)。此外,在患有ADR的儿童中,女性[41(14-105)]比男性[23(11-45)]年龄大(p=0.044)。大多数不良反应严重(75.8%),20.8%是可预防或可能可预防的;然而,大多数严重ADR(93.4%)没有后遗症。发现这些反应很可能(54.2%)或可能(45.8%)。疫苗(n=63)、抗菌药物(n=31)和抗炎药物(n=14)是最常涉及的药物。疫苗导致的器官毒性图谱为全身紊乱和给药部位状况(65.1%)、神经紊乱(50.2%)、皮肤紊乱(35%),其次是胃肠道紊乱(20.6%)。药物导致的器官毒性图谱为皮肤紊乱(76%)、胃肠道(20.7%)、全身(15.5%)和神经紊乱(8.6%)。积极的药物警戒在支持制定旨在减少因ADR住院的干预策略方面具有重要作用。我们的数据表明,ADR是儿科急诊科住院的首要原因。此外,根据文献,疫苗和抗生素是儿童药物不良反应最常见的原因。